A candidate vaccine for hepatitis B containing the complete viral surface protein
Open Access
- 1 January 1988
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 8 (1) , 82-87
- https://doi.org/10.1002/hep.1840080117
Abstract
The entire surface protein of hepatitis B virus sero-type ayw containing the preS (preS1+preS2) and S domains has been expressed in the yeast Saccharomyces cerevisiae. Yeast containing a recombinant plasmid utilizing a constitutive promoter did not express this gene successfully due to the toxicity of the protein. A plasmid using a regulatable promoter directed expression which initiated late in the exponential phase of growth and resulted in the accumulation of high intracellular levels of the complete surface protein. The purified polypeptide aggregates into a form which, although not comprised of typical 20 nm particles, displays antigenic determinants encoded by the preS1, preS2 and S domains. Immunization of rabbits elicited the formation of antibodies directed against all three domains. This candidate vaccine will be useful for studying the contributions to viral immunity of the host response to the preS1 and preS2 domains.This publication has 41 references indexed in Scilit:
- Yeast-Recombinant Hepatitis B VaccineJAMA, 1987
- A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees.Proceedings of the National Academy of Sciences, 1986
- Immunochemical structure of the hepatitis B surface antigen vaccine—II. Analysis of antibody responses in human sera against the envelope proteinsMolecular Immunology, 1986
- Distinct H-2-linked regulation of T-cell responses to the pre-S and S regions of the same hepatitis B surface antigen polypeptide allows circumvention of nonresponsiveness to the S region.Proceedings of the National Academy of Sciences, 1985
- Multiple chemical forms of hepatitis B surface antigen produced in yeast.Proceedings of the National Academy of Sciences, 1985
- The hepatitis B virusNature, 1985
- Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre‐S region of the hepatitis B virus (HBV) envelope geneJournal of Medical Virology, 1985
- Human hepatitis B vaccine from recombinant yeastNature, 1984
- The preparation and safety of hepatitis B vaccineJournal of Infection, 1983
- A controlled clinical trial of the efficacy of the hepatitis B vaccine (heptavax B): A final reportHepatology, 1981